
NfL Blood Biomarker Captures Suboptimal Treatment Response in MS
- Uncategorized
- Admin COUPONS
- September 14, 2020
Measuring levels of neurofilament light chain is an effective way of detecting disease activity and the need to optimize treatment in patients with multiple sclerosis, independent of other measures, a new study shows. Medscape Medical News
Read More